13629-82-8

Basic information

• Product Name: 3,3'-Dimethyl-4-(1,1'-biphenyl)amine
• Synonyms: 3,3'-Dimethyl-4-(1,1'-biphenyl)amine
• CAS NO: 13629-82-8
• Molecular Formula: C₁₄H₁₅N
• Molecular Weight: 197.30
• Mol File: 13629-82-8.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 324.39°C (rough estimate)
• Flash Point: 154.2 °C
• Appearance: /
• Density: 1.0514 (rough estimate)
• Refractive Index: 1.6050 (estimate)
• CAS DataBase Reference: 3,3'-Dimethyl-4-(1,1'-biphenyl)amine(CAS DataBase Reference)
• NIST Chemistry Reference: 3,3'-Dimethyl-4-(1,1'-biphenyl)amine(13629-82-8)
• EPA Substance Registry System: 3,3'-Dimethyl-4-(1,1'-biphenyl)amine(13629-82-8)

Safety Data

• Hazardous Substances Data: 13629-82-8(Hazardous Substances Data)

Upstream product

• 119-93-7 o-tolidin 
• 857569-61-0 N-(3,3'-dimethyl-biphenyl-4-yl)-acetamide 
• 13629-81-7 4-Carbamoyl-3,3'-dimethyl-biphenyl 
• 72-57-1 trypan blue 
• 3546-13-2 N-(4'-amino-3,3'-dimethyl-biphenyl-4-yl)-acetamide 
• 612-75-9 3,3'-dimethyl-biphenyl 
• 4784-72-9 4-Acetyl-3,3'-dimethyl-biphenyl 
• 13629-80-6 4-Chlorcarbonyl-3,3'-dimethyl-biphenyl 
• 13629-79-3 3,3'-Dimethyl-4-carboxy-biphenyl 
• 17933-03-8 m-tolylboronic acid 
• 583-75-5 4-Bromo-2-methylaniline 

Downstream Products

• 4575-13-7 2,3,3′,3′′′-tetramethyl-1,1′:4′1:4,1′′′-quaterphenyl 

Relevant articles and documents

COMPOUNDS MODULATING ACTIVITY OF FARNESOID X RECEPTOR AND METHODS FOR THE USE THEREOF

Compounds such as vidofludimus and its analogues useful in modulating the activity of nuclear receptor FXR. Also disclosed are the methods for treating FXR-mediated disease or process in a mammal, comprising administering to the mammal a therapeutically effective amount of a compound claimed, wherein the FXR-mediated disease or condition linked to chronic liver diseases such as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, inflammatory diisease such as rheumatoid arthritis and inflammatory bowel disease, cardiovascular diseases, or metabolic diseases such as diabetes and obesity.